Apoliproteina E vinculado a una mayor susceptibilidad al SARS-CoV-2

Atkins J, Masoli J, Delgado J, Pilling L, Kuo C, Kuchel G, et al. Preexisting comorbidities predicting severe COVID-19 in older adults in the UK Biobank Community Cohort. J Gerontol. 2020;75(11):2224-30. https://doi.org/10.1093/gerona/glaa183

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. https://doi.org/10.1101/2020.04.23.20076042

Kasparian K, Graykowski D, Cudaback E. Commentary: APOE e4 genotype predicts severe COVID-19 in the UK Biobank Community Cohort. Front Immunol. 2020;11:1939. https://doi.org/10.3389/fimmu.2020.01939

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90. https://doi.org/10.1001/jamaneurol.2020.H27

Kuo CL, Pilling LC, Atkins JL, Kuchel GA, Melzer D. ApoE ?2 and aging-related outcomes in 379,000 UK Biobank participants. Aging. 2020;12(12):12222-33. https://doi.org/10.18632/aging.103405

Giau VV, Bagyinszky E, An SS, Kim SY Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat. 2015;11:1723-37. https://doi.org/10.2147/NDT.S84266

Singh PP, Singh M, Mastana SS. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol. 2006;33(3):279-308. https://doi.org/10.1080/03014460600594513

Marais A. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Pathology. 2019;51(2):165-76. https://doi.org/10.1016/j.pathol.2018.11.002

Gkouskou K, Vasilogiannakopoulou T, Andreakos E, Davanos N, Gazouli M, Sanoudou D, et al. COVID-19 enters the expanding network of apolipoprotein E4-related pathologies. Redox Biology. 2021;41:2213-17. https://doi.org/10.1016/j.redox.2021.101938

Wang G, Zhang Q, Zhao X, Dong H, Wu Ch, Wu F. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study Lipids Health Dis. 2020;19(1):204. https://doi.org/10.1186/s12944-020-01382-9

Angelidis I, Simon LM, Fernandez IE, Strunz M, Mayr CH, Greiffo FR, et al. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nature Commun. 2019;10(1):963. https://doi.org/10.1038/s41467-019-08831-9

Gale SC, Gao L, Mikacenic C, Coyle SM, Rafaels N, Murray Dudenkov T, et al. APOs4 is associated with enhanced in vivo innate immune responses in human subjects. J Allergy Clin Immunol. 2014;134(1):127-34. https://doi.org/10.1016/j.jaci.2014.01.032

Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Cliakhoyan A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71-6. https://doi.org/10.1038/s41586-020-2247-3

Blanchard JW Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, et al. Reconstruction of the human blood-brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26(6):952-63. https://doi.org/10.1038/s41591-020-0886-4

Inal J. Biological factors linking ApoE s4 variant and severe COVID-19. Curr Atheroscler Rep. 2020;22:70. https://doi.org/10.1007/s11883-020-00896-y

Rieker C, Migliavacca E, Vaucher A, Mayer F, Baud G, Marqués J, et al. Apolipoprotein E4 expression causes gain of toxic function in isogenic human induced pluripotent stem cell-derived endo-thelial cells. Arterioscler Thromb Vasc Biol. 2019;39(9):e195-207. https://doi.org/10.1161/ATVBAHA.118.312261